Liquid Immunoglobulin G (Lgg) Product

Patent No. EP2270044 (titled "Liquid Immunoglobulin G (Lgg) Product") was filed by CSL Behring on Jun 9, 1999. The application was issued on Nov 5, 2014.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
OCTAPHARMAAug 5, 2015ULLRICH & NAUMANN PARTG MBB
BAXALTAJul 31, 2015HOFFMANN EITLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2270044

CSL BEHRING
Application Number
EP10011725A
Filing Date
Jun 9, 1999
Status
Revoked
Sep 13, 2019
Publication Date
Nov 5, 2014